Serum levels of N-terminal PRO-BRAIN natriuretic peptide in hypertensive disorders of pregnancy
Open Access
- 11 September 2026
- journal article
- Published by State Institution of Science "Center of Innovative Healthcare Technologies" State Administrative Department in Clinical and Preventive Medicine
- No. 6,p. 95-101
Abstract
Introduction. Hypertensive disorders of pregnancy (HDP) are among the leading causes of maternal and perinatal morbidity and mortality. This necessitates improvement of early diagnostic and prognostic approaches. Impaired cardiovascular adaptation, increased vascular resistance, and endothelial dysfunction play key roles in their pathogenesis. N-terminal pro-brain natriuretic peptide (NT-proBNP), a biomarker reflecting myocardial hemodynamic load, appears promising; however, its prognostic value in gestational hypertension (GH) and preeclampsia (PE) remains to be fully established.Aim. To evaluate the association between serum NT-proBNP levels and the development of HDP and to assess its prognostic potential.Materials and methods. A total of 119 pregnant women were enrolled and divided into three groups: 61 women with HDP (46 with GH and 15 with moderate PE), 48 women at high risk of HDP, and 25 women with uncomplicated pregnancies (control group). All participants underwent clinical examination, 24-hour blood pressure (BP) monitoring, and serum NT-proBNP measurement using enzyme-linked immunosorbent assay. Statistical analysis was performed using Statistica 12 and MedCalc®.Results. NT-proBNP levels were 3.4-fold higher in women with GH compared to controls (196.41 ± 17.28 vs. 56.16 ± 6.62 pg/mL, p = 0.000) and 4.7-fold higher in women with PE compared to controls (264.73 ± 9.13 vs. 56.16 ± 6.62 pg/mL, p = 0.000). NT-proBNP levels were 1.3-fold higher in PE compared to GH (p = 0.000). In the high-risk group, women who subsequently developed HDP had significantly higher NT-proBNP levels in the second trimester compared to controls (87.71 ± 8.56 vs. 56.16 ± 6.62 pg/mL, p = 0.006) and compared to women who remained normotensive (87.71 ± 8.56 vs. 62.79 ± 5.50 pg/mL, p = 0.018). A strong positive correlation was observed between NT-proBNP levels and mean daily systolic BP in women with HDP (r = 0.81, p = 0.000) and a moderate positive correlation in the high-risk group (r = 0.54, p = 0.000).Conclusions. Elevated NT-proBNP levels are associated with HDP. NT-proBNP may serve as an informative biomarker for early detection, risk stratification, and clinical monitoring of patients with GH and PE.Keywords
This publication has 16 references indexed in Scilit:
- Prognostic value of maternal N‐terminal pro‐B‐type natriuretic peptide for prediction of severe maternal adverse outcome in women with pre‐eclampsiaUltrasound in Obstetrics & Gynecology, 2025
- Maternal coronary heart disease and mortality following hypertensive disorders of pregnancy and/or diabetesCardiovascular Diabetology, 2025
- Hypertensive disorders of pregnancy: impact on future blood pressure and cardiovascular diseaseHypertension Research, 2024
- Early-pregnancy N-terminal pro-brain natriuretic peptide level is inversely associated with hypertensive disorders of pregnancy diagnosed after 35 weeks of gestationScientific Reports, 2024
- Evaluating circulating soluble markers of endothelial dysfunction and risk factors associated with PE: A multicentre longitudinal case control study in northern GhanaHeliyon, 2023
- Hypertensive disorders of pregnancy and long‐term cardiovascular health: FIGO Best Practice AdviceInternational Journal of Gynecology & Obstetrics, 2023
- Myocardial Mechanics in Hypertensive Disorders of Pregnancy: a Systematic Review and Meta-AnalysisHypertension, 2022
- Circulating NT-proBNP but not soluble corin levels were associated with preeclampsia in pregnancy-associated hypertensionClinical Biochemistry, 2019
- N-terminal pro B-type natriuretic peptide and angiogenic biomarkers in the prognosis of adverse outcomes in women with suspected preeclampsiaClinica Chimica Acta, 2016
- Natriuretic peptides and hemodynamics in preeclampsiaAmerican Journal of Obstetrics and Gynecology, 2007